160 related articles for article (PubMed ID: 21484430)
1. The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma.
Wilkens L; Jaggi R; Hammer C; Inderbitzin D; Giger O; von Neuhoff N
Virchows Arch; 2011 Jun; 458(6):697-708. PubMed ID: 21484430
[TBL] [Abstract][Full Text] [Related]
2. Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.
Wildenhain S; Ingenhag D; Ruckert C; Degistirici Ö; Dugas M; Meisel R; Hauer J; Borkhardt A
J Biol Chem; 2012 Nov; 287(48):40703-12. PubMed ID: 23048027
[TBL] [Abstract][Full Text] [Related]
3. A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression.
Su J; You P; Zhao JP; Zhang SL; Song SH; Fu ZR; Ye LW; Zi XY; Xie DF; Zhu MH; Hu YP
Med Oncol; 2012 Jun; 29(2):1059-67. PubMed ID: 21656028
[TBL] [Abstract][Full Text] [Related]
4. HLXB9 gene expression, and nuclear location during in vitro neuronal differentiation in the SK-N-BE neuroblastoma cell line.
Leotta CG; Federico C; Brundo MV; Tosi S; Saccone S
PLoS One; 2014; 9(8):e105481. PubMed ID: 25136833
[TBL] [Abstract][Full Text] [Related]
5. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
[TBL] [Abstract][Full Text] [Related]
6. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
7. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.
Cui H; Wu F; Sun Y; Fan G; Wang Q
BMC Cancer; 2010 Jul; 10():356. PubMed ID: 20604928
[TBL] [Abstract][Full Text] [Related]
9. High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models.
Quagliata L; Quintavalle C; Lanzafame M; Matter MS; Novello C; di Tommaso L; Pressiani T; Rimassa L; Tornillo L; Roncalli M; Cillo C; Pallante P; Piscuoglio S; Ng CK; Terracciano LM
Lab Invest; 2018 Jan; 98(1):95-105. PubMed ID: 29035381
[TBL] [Abstract][Full Text] [Related]
10. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated paired related homeobox 1 impacts on hepatocellular carcinoma phenotypes.
Piorońska W; Nwosu ZC; Han M; Büttner M; Ebert MP; Dooley S; Meyer C
BMC Cancer; 2021 Sep; 21(1):1006. PubMed ID: 34496784
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
[TBL] [Abstract][Full Text] [Related]
14. Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9.
Li H; Arber S; Jessell TM; Edlund H
Nat Genet; 1999 Sep; 23(1):67-70. PubMed ID: 10471501
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
16. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
[TBL] [Abstract][Full Text] [Related]
18. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
19. SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation.
Acun T; Oztas E; Yagci T; Yakicier MC
BMC Cancer; 2011 Jun; 11():223. PubMed ID: 21645397
[TBL] [Abstract][Full Text] [Related]
20. DEC1 nuclear expression: a marker of differentiation grade in hepatocellular carcinoma.
Shi XH; Zheng Y; Sun Q; Cui J; Liu QH; Qü F; Wang YS
World J Gastroenterol; 2011 Apr; 17(15):2037-43. PubMed ID: 21528084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
